News Industry News LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients May 05, 2017
News Industry News LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial April 04, 2016
News Industry News Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses October 06, 2015